Overview

Study of the Effects of BMS-919373 on the Electrical Activity of the Heart Using Pacemakers

Status:
Terminated
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
To determine the effect of our compound (BMS-919373) on electrical activity of the heart using pacemakers.
Phase:
Phase 1
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Sotalol